LFB USA

LFB USA is a subsidiary of the LFB Group, a leading European biopharmaceutical company that develops, manufactures, and markets plasma-derived medicinal products and recombinant proteins. LFB USA specifically focuses on the development and manufacturing of recombinant proteins using its proprietary rPRO™ technology, which expresses proteins in the milk of transgenic animals. The company provides development, manufacturing, and regulatory services to its parent company, LFB S.A., and other partners. Its primary mission is to provide innovative treatments for serious and rare diseases, particularly in the fields of hemostasis, immunology, and intensive care. LFB USA operates a state-of-the-art manufacturing facility in Charlton, MA, and is headquartered in Framingham, MA.